Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Nano-X Imaging Ltd. (NNOX : NSDQ)
 
 • Company Description   
NANO-X IMAGING LTD is a medical imaging technology company. NANO-X IMAGING LTD is based in Neve Ilan, Israel.

Number of Employees: 186

 
 • Price / Volume Information   
Yesterday's Closing Price: $5.95 Daily Weekly Monthly
20 Day Moving Average: 561,767 shares
Shares Outstanding: 52.08 (millions)
Market Capitalization: $309.88 (millions)
Beta: 1.90
52 Week High: $16.44
52 Week Low: $5.62
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -19.05% -17.74%
12 Week -15.36% -17.49%
Year To Date -19.38% -21.61%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
COMMUNICATIONS CENTER
-
NEVE ILAN,L3 9085000
ISR
ph: 972-02-536-0360
fax: 972-02-544-5214
bob@lifesciadvisors.com None
 
 • General Corporate Information   
Officers
Ran Poliakine - Chief Executive Officer and Chairman of the Board
James Dara - Chief Operating Officer
Itzhak Maayan - Chief Financial Officer
Tal Shank - Vice President Corporate Development
Onn Fenig - Director

Peer Information
Nano-X Imaging Ltd. (EVOL)
Nano-X Imaging Ltd. (RAMP)
Nano-X Imaging Ltd. (ALOT)
Nano-X Imaging Ltd. (TGHI)
Nano-X Imaging Ltd. (GNCMA)
Nano-X Imaging Ltd. (GSIC)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Technology Services
Sector: Business Services
CUSIP: M70700105
SIC: 3844
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/22
Next Expected EPS Date: 05/18/23
Share - Related Items
Shares Outstanding: 52.08
Most Recent Split Date: (:1)
Beta: 1.90
Market Capitalization: $309.88 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.37 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/18/23  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.38
Price/Cash Flow: -
Price / Sales: 36.12
EPS Growth
vs. Year Ago Period: -95.45%
vs. Previous Quarter: -132.43%
Sales Growth
vs. Year Ago Period: 63.50%
vs. Previous Quarter: -12.55%
ROE
12/31/22 - -41.61
09/30/22 - -30.56
06/30/22 - -29.55
ROA
12/31/22 - -34.38
09/30/22 - -24.72
06/30/22 - -24.65
Current Ratio
12/31/22 - 4.83
09/30/22 - 2.08
06/30/22 - 2.21
Quick Ratio
12/31/22 - -
09/30/22 - 2.08
06/30/22 - 2.21
Operating Margin
12/31/22 - -1,226.89
09/30/22 - -1,063.76
06/30/22 - -
Net Margin
12/31/22 - -1,226.89
09/30/22 - -1,063.76
06/30/22 - -
Pre-Tax Margin
12/31/22 - -1,269.77
09/30/22 - -1,098.52
06/30/22 - -1,488.70
Book Value
12/31/22 - 4.31
09/30/22 - 4.76
06/30/22 - 5.04
Inventory Turnover
12/31/22 - -
09/30/22 - -
06/30/22 - -
Debt-to-Equity
12/31/22 - 0.02
09/30/22 - 0.01
06/30/22 - 0.01
Debt-to-Capital
12/31/22 - 1.53
09/30/22 - 1.39
06/30/22 - 1.31
 

Powered by Zacks Investment Research ©